503. Clonal Hematopoiesis, Aging, and Inflammation: Poster II

Clonal Hematopoiesis Is Associated with Changes to T Cell Contexture in Solid Tumours

Clonal Hematopoiesis of Indeterminate Potential Is Associated with Decreased Inflammatory Toxicity and Increased Late Cytopenia in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma Treated with Chimeric Antigen Receptor T-Cell Therapy

Dysregulation of the Ubiquitination Pathway: Insights on Autoinflammatory Conditions and Inborn Errors of Immunity in Bone Marrow Failure Disorders

Gut Microbiota Promote Chronic Inflammation in Jak2V617F Mice

Low Regimen Therapeutic Strategies to Mitigate TET2 Mutant Clonal Hematopoiesis

MYD88 Is Mutated in Clonal Hematopoiesis and Drives Altered Immune Cell Populations

Mutagenic DNA Lesions in Normal Hematopoietic Stem Cells Persist for Years Causing Distinct Patterns of Mutation

Primary Hematopoietic Cells of Vexas Patients Are Highly Sensitive to Treatment with TAK-243 and Pevonedistat

Single Cell Multiomic Analysis of Bone Marrow Hematopoietic Stem/Progenitor Cells from Individuals with Clonal Hematopoiesis Reveals Potential Mechanisms of Anemia Development

Targeting Inflammation in Tet2 Mutant Clonal Hematopoiesis Via Inhibition of Brd4 Demonstrates Activity in Both Murine and Human Models